Evidence Synthesis
ELIXIR Sees Significant Improvement in Revenue Growth and Gross Margin ELIXIR's revenue growth slowed down to 73.9% from 124.7%, indicating a deceleration in the company's growth trajectory.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 6 Sept 2026, 16:39
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
ELIXIR Sees Significant Improvement in Revenue Growth and Gross Margin ELIXIR's revenue growth slowed down to 73.9% from 124.7%, indicating a deceleration in the company's growth trajectory.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 99.46 % | 60.99 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 60.99 % | 15.21 | ▲ |
| REVENUE_GROWTH_YOY | 73.9 % | 124.7 | ▼ |
| PRICE_CHANGE_PERCENT | 0.098 % | — | - |
| DAILY_VOLUME | 2,347 shares | 2,317 | ▲ |
| CLOSE_PRICE | 102 INR | 101.9 | ▲ |